Bone Grafts for Tooth Extractions
(FDBA or CEBX Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines two different bone graft materials to determine which better preserves bone after a front tooth extraction and before a dental implant. One group will receive freeze-dried bone material (FDBA), while the other will receive collagen-enriched cow bone material (CEBX). The researchers aim to identify differences in bone healing and patient satisfaction. Individuals needing a front tooth extraction and planning for a dental implant may qualify if they have specific bone issues, such as a small gap in the bone. As an unphased trial, this study provides an opportunity to explore innovative materials for dental health.
Will I have to stop taking my current medications?
The trial requires that you do not take certain medications like immunosuppressants, steroids, bisphosphonates, or others related to jaw bone issues. If you are on these medications, you may need to stop them to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
In a previous study, patients who received freeze-dried bone allograft (FDBA) experienced good wound healing over 12 weeks, indicating that the graft material was well-accepted by the body, with no major safety issues reported. Another study found that FDBA led to significant new bone growth, a positive sign for its safety and effectiveness.
For collagen-enriched bovine xenograft (CEBX), research has shown it aids in bone healing after tooth removal, suggesting it is also well-accepted by the body. However, some reports have mentioned possible long-term risks, though these are uncommon.
Both FDBA and CEBX are regularly used in dental procedures, supporting their general safety. No major side effects or complications have been frequently reported with either treatment.12345Why are researchers excited about this trial's treatments?
Researchers are excited about the treatments CEBX and FDBA for bone grafts following tooth extractions because they offer unique benefits compared to traditional options like autografts and allografts. CEBX is distinctive because it acts as an active comparator, potentially providing a more predictable integration with the existing bone. On the other hand, FDBA, a freeze-dried bone allograft, is being explored for its ease of use and reduced risk of disease transmission. These innovations could lead to improved healing times and outcomes for patients needing bone grafts after tooth removal.
What evidence suggests that this trial's treatments could be effective for preserving bone after tooth extraction?
Research has shown that freeze-dried bone allograft (FDBA), one of the treatments in this trial, effectively maintains bone after tooth removal. Studies indicate that after 15 months, the bone's width and height remain about 91% of their original size, suggesting FDBA effectively preserves bone structure. Additionally, around 18-20 weeks after using FDBA, about 36% of the new bone is healthy and living.
Collagen-enriched bovine xenograft (CEBX) is another treatment option in this trial for preserving bone. While specific numbers aren't provided here, it is known for naturally supporting bone healing. Both treatments in this trial aim to keep the bone stable and ready for future dental implants.678910Who Is on the Research Team?
Elli Anna Kotsailidi, DDS, MS
Principal Investigator
Eastman Institute for Oral Health, University of Rochester
Are You a Good Fit for This Trial?
This trial is for individuals needing a front tooth extracted and replaced with an implant. They should be suitable for bone grafting procedures using either human (FDBA) or cow-derived (CEBX) materials. Specific eligibility criteria are not provided, but typically participants must be in good general health and have adequate bone structure to support the dental work.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo tooth extraction and alveolar ridge preservation with either FDBA or CEBX, followed by healing
Implant Placement and Crown Restoration
Implant placement and crown restoration are performed after healing
Follow-up
Participants are monitored for safety, effectiveness, and esthetic outcomes after implant placement
What Are the Treatments Tested in This Trial?
Interventions
- CEBX
- FDBA
CEBX is already approved in European Union, United States, Canada for the following indications:
- Dental implantology
- Bone augmentation
- Sinus floor elevation
- Ridge preservation
- Dental implantology
- Bone augmentation
- Sinus floor elevation
- Ridge preservation
- Dental implantology
- Bone augmentation
- Sinus floor elevation
- Ridge preservation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Rochester
Lead Sponsor
Implant Dentistry Research & Education Foundation (IDREF)
Collaborator